NCT04366102

Brief Summary

To determine the effects of multisensory stimulation and soft tissue therapy on procedural pain and neurodevelopment among neonates admitted to the NICU is the aim of the study. The study will be two groups randomized clinical trial of five days intervention program. The intervention will be given among two groups. Group A will receive both multisensory stimulation and soft tissue therapy, Group B will receive only regular hospital care. The PIPP and N-PASS will be used for assessing pain. The INFANIB and Premie-Neuro will be used for assessing neuromotor development among neonates. The outcomes will be taken before and after the fifth day of the intervention. Multisensory stimulation and soft tissue therapy might help in reducing pain and promoting neurodevelopment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 28, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

October 22, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

2.9 years

First QC Date

April 25, 2020

Last Update Submit

August 3, 2024

Conditions

Keywords

NeonatesPain

Outcome Measures

Primary Outcomes (2)

  • The Premature infant pain profile-Revised (PIPP-R)

    Measuring procedural pain among neonates, having 1 to 3 scoring. 0 describe normal and 3 describes low score

    Change score of PIPP at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention

  • Neonatal pain agitation sedation scale (N-PASS)

    Measuring procedural pain along with sedation, having score ranged from 0 to 2, 0 describes normal and 2 describes low score

    Change score of N-PASS at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention

Secondary Outcomes (2)

  • Infant neurological international battery (INFANIB)

    Change score of INFANIB at the baseline and after five days of intervention

  • Premie-Neuro

    Change score of Premie-Neuro at the baseline and after five days of intervention

Study Arms (2)

Group A

EXPERIMENTAL

Multisensory stimulation and soft tissue therapy

Other: Multisensory stimulation with soft tissue therapy

Group B

EXPERIMENTAL

Routine Hospital care

Other: Routine hospital care

Interventions

Multisensory stimulation with soft tissue therapy will be given. Multisensory stimulation consists of Auditory, vestibular, tactile, olfactive, oromotor, Visual, and Kinesthetic stimulation. Soft tissue therapy consists of stroking, effleurage, fingertip kneading, tapping, and skin rolling will be given. Total intervention will be given for 30 min. 5 times per week

Group A

Routine hospital care will be given to the preterm neonates

Group B

Eligibility Criteria

Age24 Hours - 5 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Preterm between 30- 36 weeks of gestation
  • Birth weight \>1000 g
  • Not receiving analgesics/sedatives
  • APGAR score ranged between 4-6 in 1 min. \& 7 to 9 in 5 min.
  • Undergoing routine healthcare procedures in NICU

You may not qualify if:

  • Preterm with surgery
  • Preterm having unstable vitals
  • Preterm with congenital malformations
  • Preterm who require mechanical ventilation
  • Having inborn errors of metabolism and also with seizures disorders,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Unit, Maharishi Markandeshwar Hospital

Ambāla, Haryana, 133207, India

Location

Related Publications (3)

  • Zeraati H, Nasimi F, Rezaeian A, Shahinfar J, Ghorban Zade M. Effect of Multi-sensory Stimulation on Neuromuscular Development of Premature Infants: A Randomized Clinical Trial. Iran J Child Neurol. 2018 Summer;12(3):32-39.

    PMID: 30026767BACKGROUND
  • de Melo GM, Lelis AL, de Moura AF, Cardoso MV, da Silva VM. [Pain assessment scales in newborns: integrative review]. Rev Paul Pediatr. 2014 Dec;32(4):395-402. doi: 10.1016/j.rpped.2014.04.007.

    PMID: 25511005BACKGROUND
  • Sharma N, Samuel AJ. Multisensory Stimulation and Soft Tissue Therapy on Pain and Neurodevelopment Among Preterm Neonates. Pediatr Phys Ther. 2022 Apr 1;34(2):277-282. doi: 10.1097/PEP.0000000000000887.

Related Links

MeSH Terms

Conditions

Infant, Newborn, DiseasesPain

Interventions

Therapy, Soft Tissue

Condition Hierarchy (Ancestors)

Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Neha Sharma, MPT

    Maharishi Markandeshwar institute of Physiotherapy and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • Asir J Samuel, MPT, PhD

    Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation

    STUDY CHAIR
  • Kusum Mahajan, MD

    Maharishi Markandeshwar Institute of Medical Sciences & Research

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Neonates admitted in the Neonatal intensive care unit will be divided randomly into 2 groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

April 25, 2020

First Posted

April 28, 2020

Study Start

October 22, 2020

Primary Completion

September 16, 2023

Study Completion

October 20, 2023

Last Updated

August 6, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

Individual participant data (IPD) will be shared via Mendeley Dataset

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Study Protocol - December, 2020 Statistical Analysis Plan (SAP) - December, 2020 Informed Consent Form (ICF) - December, 2020
Access Criteria
By publishing study protocol with detailed statistical Analysis Plan in SCOPUS and PubMed indexed journals

Locations